Optimizing haemodiafiltration: tools, strategy and remaining questions.

Fig. 1. Suggested flow diagram for reporting of long-term major adverse events after coronary angiography with iodinated contrast in the CARE trial. revascularization. Perhaps a future report from the CARE trial can inform the reader about these 38 subjects, particularly those who suffered CI-AKI with respect to their courses of treatment and care in the year of follow-up after the trial. By filling in the circles and boxes in Figure 1, the authors could allow inferences on translation of CK-AKI into long-term adverse events and the issue of cause and effect.